Vision impairment disproportionately impacts older adults
Tag: Geriatics
There’s a Better Way to Detect High-Risk Medications in Older Adults with Cancer According to New Study in JNCCN
Gerontology researchers teamed up with hematologic-oncology investigators from Brigham and Women’s Hospital and the Dana-Farber Cancer Institute to look at the association between older patients with blood cancers who were taking multiple medications and their corresponding frailty. They also created a new scale based on a list of Potentially Inappropriate Medications (PIMs) from the NCCN Guidelines® for Older Adult Oncology—called the Geriatric Oncology-Potentially Inappropriate Medications (GO-PIMs) Scale—and found it to be more effective at predicting frailty than conventional methods.
Diagnosis of Alzheimer’s and Related Dementias Reduces Social Activity
Despite the belief that early diagnosis of Alzheimer’s disease and other dementias is crucial, a new Rutgers study found that the diagnosis may unintentionally impact social relationships and activity.
Mount Sinai Health System to Launch Palliative Care at Home, Expanding Partnership With Contessa
Today Mount Sinai announces Palliative Care at Home, a program to care for seriously ill patients in the comfort and safety of their own homes, while avoiding unnecessary hospitalizations.
Rutgers Launches Population Aging Concentration
The Rutgers School of Public Health has launched a Population Aging Concentration within the Department of Health Behavior, Society, and Policy.
Family Caregiving May Not Harm Health of Caregivers After All
For decades, family caregiving has been thought to create a type of chronic stress that may lead to significant health risks or even death, alarming potential caregivers and presenting a guilt-ridden obstacle for those needing help.
Many Elderly Patients with Metastatic Renal Cell Carcinoma Benefit from Targeted Therapies
Penn Study Investigated Real-World Treatment Outcomes Among Medicare Patients PHILADELPHIA—Many elderly patients with metastatic renal cell carcinoma (RCC)—who are often underrepresented in clinical trials to treat the kidney cancer—are seeing overall survival benefits from treatment with targeted therapies, according to…